Meeting
2021 ASCO Annual Meeting
Association of low RKIP expression with poor prognosis in non-small cell lung cancer.
Authors
Lingbin Meng
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Lingbin Meng , Rui Ji , Damian A. Laber , Xuebo Yan , Xiaochun Xu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
New Targets and New Technologies (non-IO)
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3068)
DOI
10.1200/JCO.2021.39.15_suppl.3068
Abstract #
3068
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Effect of primary tumor size in patients with metastatic non-small cell lung cancer (NSCLC).
First Author: Bing Xia
Poster
2023 ASCO Annual Meeting
The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.
First Author: Jhanelle Elaine Gray
Poster
2021 ASCO Annual Meeting
Population-based impacts of new therapies on outcomes for stage IV non-small cell lung cancer.
First Author: Rebekah Rittberg
Poster
2021 Genitourinary Cancers Symposium
Association of survival and local radiotherapy to the bladder versus chemotherapy alone for patients with metastatic urothelial carcinoma (mUC).
First Author: Benjamin Walker Fischer-Valuck